OneDigital Investment Advisors’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-300
Closed -$8K 758
2021
Q4
$8K Buy
300
+100
+50% +$3.68K ﹤0.01% 787
2021
Q3
$1K Buy
+200
New +$7.79K ﹤0.01% 761
2021
Q1
Sell
-800
Closed -$4K 700
2020
Q4
$4K Buy
+800
New +$59.8K ﹤0.01% 681

Other funds holding AXSM

OneDigital Investment Advisors's AXSM Position: Q2 2026 in Review

OneDigital Investment Advisors reduced its Axsome Therapeutics (AXSM) stake by 5.8% in Q2 2026, selling an estimated $103K and leaving 7,787 shares worth $1.91M. The position accounts for 0.02% of the portfolio, ranked #517.

OneDigital Investment Advisors first reported a position in AXSM in Q2 2019 and has held it in 25 quarters since. 191 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • OneDigital Investment Advisors held 7,787 shares of Axsome Therapeutics worth $1.91M as of Q2 2026.
  • OneDigital Investment Advisors sold 477 Axsome Therapeutics shares in Q2 2026, an estimated $103K.
  • Axsome Therapeutics made up 0.02% of OneDigital Investment Advisors's portfolio in Q2 2026, its #517 holding.
  • OneDigital Investment Advisors first reported a position in Axsome Therapeutics in Q2 2019 and has held it in 25 quarters since.
  • 191 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on OneDigital Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.